ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

New Center to Accelerate Biological Design for Sustainable Fuel and Bioproduct Production – Northwestern University NewsCenter

Continue reading

2017-10-17 Michael Zand NEWS

New Center to Accelerate Biological Design for Sustainable Fuel and Bioproduct Production – Northwestern University NewsCenter

New Center to Accelerate Biological Design for Sustainable Fuel and Bioproduct Production
Northwestern University NewsCenter
Michael Koepke, who leads LanzaTech’s synthetic biology team, is a leading expert in genomically manipulating clostridia. He and Jewett have been collaborating for the past two years to engineer clostridia to produce sustainable fuels, but engineering …

Continue reading

2017-10-17 Michael Zand NEWS

Cascade of Costs Could Push Gene Therapy Over $1 Million Per Patient – Managed Care magazine

MedscapeCascade of Costs Could Push Gene Therapy Over $1 Million Per PatientManaged Care magazineOutrage over the cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the first U.S. gene therapy, tisagenlecl… Continue reading

2017-10-17 Michael Zand NEWS

MeiraGTx Presents Preclinical Data on its Ocular Gene Therapy Studies for the Treatment of Leber’s Congenital … – PR Newswire (press release)

New Center to Accelerate Biological Design for Sustainable Fuel and Bioproduct Production
Northwestern University NewsCenter
Michael Koepke, who leads LanzaTech’s synthetic biology team, is a leading expert in genomically manipulating clostridia. He and Jewett have been collaborating for the past two years to engineer clostridia to produce sustainable fuels, but engineering …

Continue reading

2017-10-17 Michael Zand NEWS

This Startup Turns Climate Pollution Into Fish Feed – Fast Company

MeiraGTx Presents Preclinical Data on its Ocular Gene Therapy Studies for the Treatment of Leber’s Congenital …
PR Newswire (press release)
NEW YORK and BERLIN, Oct. 17, 2017 /PRNewswire/ — MeiraGTx, a New York and London based gene therapy company, today announced the presentation of preclinical data from studies in animal models of Leber’s congenital amaurosis (LCA2), …

and more »

Continue reading

2017-10-17 Michael Zand NEWS

Columbus Venture Partners and AskBio launch gene therapy joint venture – PE Hub (blog)

Columbus Venture Partners and AskBio launch gene therapy joint venturePE Hub (blog)AskBio and Columbus Venture Partners have formed Viralgen, a gene therapy joint venture. In addition to funding from AskBio and Columbus Venture Partners, Viralgen, whic… Continue reading

2017-10-17 Michael Zand NEWS

Asia Regulatory Roundup: India Tightens Stem Cell Guidelines (17 September 2017) – Regulatory Focus

SeekerAsia Regulatory Roundup: India Tightens Stem Cell Guidelines (17 September 2017)Regulatory FocusIndia has tightened its guidelines on the banking and therapeutic use of stem cells in response to “rampant unethical practices.” The updated guidelin… Continue reading

2017-10-17 Michael Zand NEWS

Upfront Immunotherapy for NSCLC – OncLive


Fast Company

This Startup Turns Climate Pollution Into Fish Feed
Fast Company
The company is also developing new microbes, using synthetic biology, that can produce particular nutrients–vitamins or probiotics, for example–that can also be used as ingredients in feed. [Photo: Novonutrients] The startup’s process uses carbon …

Continue reading

2017-10-17 Michael Zand NEWS
  • 1
  • …
  • 1,039
  • 1,040
  • 1,041
  • 1,042
  • 1,043
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

OncLive

Upfront Immunotherapy for NSCLC
OncLive
We’re going to talk first about immuno-oncology and immunotherapy. As you’re aware of, immunotherapy is now clearly a very exciting advance in the treatment of lung cancer. We’ve seen several approvals for agents targeting the immune checkpoint …

and more »